the effect of IRONPLUS treatment of iron deficiency anemia

Comparison of the efficacy and effectiveness of combined herbal preparations containing iron ( Iron Plus tablet) in treatment of anemia in patients with iron deficiency anemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201506211165N6

Enrollment

120

Registered

2015-09-04

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IRON DEFICIENCY ANEMIA. Iron deficiency anaemia

Interventions

Intervention 1: to 12 weeks cost intervention group a herbal preparation Iron Plus 325 mg (3 tablets a day ) will receiveBlood tests will be repeated after 12 weeks. Intervention 2: to 12 weeks cost

Treatment - Drugs

to 12 weeks cost intervention group a herbal preparation Iron Plus 325 mg (3 tablets a day ) will receiveBlood tests will be repeated after 12 weeks

to 12 weeks cost control group and one FERFOLIC at a dose of 325mg (3 tablets a day )will receiveBlood tests will be repeated after 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria:Obtaining the informed consent of the patient?Group of iron deficiency anemia Exclusion criteria:Failure to complete the course of treatment or use instructions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
FERRITIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TIBC. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TRANSFERIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;SERUM IRON. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;RDW. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;HCT HB. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;MCV MCH. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;PROTOPURPHIRIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.	—

Measure

Time frame

FERRITIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TIBC. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TRANSFERIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;SERUM IRON. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;RDW. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;HCT HB. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;MCV MCH. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;PROTOPURPHIRIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.

—

Secondary

Measure	Time frame
SIDE EFFECTS OF DRUG. Timepoint: AFTER Prescription OF DRUG. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMr. Dr. Yunes Panahi

Baqiatala Hospital

YUNESPANAHI@YAHOO.COM+98 88050435

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026